Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidermolysis Bullosa (EB)”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06594393
What this trial is testing

TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

Who this might be right for
Epidermolysis Bullosa (EB)Dystrophic Epidermolysis BullosaJunctional Epidermolysis Bullosa
Xinnate AB 32
Early research (Phase 1)Active Not RecruitingNCT06713434
What this trial is testing

Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa

Who this might be right for
Junctional Epidermolysis BullosaEpidermolysis Bullosa (EB)Dystrophic Epidermolysis Bullosa+1 more
Fundación DEBRA Chile, Niños Piel de Cristal 20
Testing effectiveness (Phase 2)Study completedNCT02582775
What this trial is testing

MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs

Who this might be right for
Epidermolysis Bullosa
Masonic Cancer Center, University of Minnesota 17
Testing effectiveness (Phase 2)Study completedNCT02654483
What this trial is testing

Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients

Who this might be right for
Epidermolysis BullosaPruritus
Jean Yuh Tang 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07011589
What this trial is testing

Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa AcquisitaRecessive Dystrophic Epidermolysis Bullosa+1 more
M. Peter Marinkovich 18
Testing effectiveness (Phase 2)Study completedNCT01033552
What this trial is testing

Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs

Who this might be right for
Epidermolysis Bullosa
Masonic Cancer Center, University of Minnesota 32
Testing effectiveness (Phase 2)Looking for participantsNCT06509984
What this trial is testing

A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized

Who this might be right for
Epidermolysis Bullosa SimplexGenodermatosis
Centre Hospitalier Universitaire de Nice 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05464381
What this trial is testing

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)

Who this might be right for
Epidermolysis Bullosa
RHEACELL GmbH & Co. KG 91
Testing effectiveness (Phase 2)WithdrawnNCT01528306
What this trial is testing

A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Healthpoint
Large-scale testing (Phase 3)Active Not RecruitingNCT05838092
What this trial is testing

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)

Who this might be right for
Epidermolysis Bullosa
RHEACELL GmbH & Co. KG 9
Testing effectiveness (Phase 2)Study completedNCT03468322
What this trial is testing

A Double-blind, Intra-individual Comparison, POC Trial of AC-203 in EB Patients

Who this might be right for
Inherited Epidermolysis Bullosa
TWi Biotechnology, Inc. 9
Not applicableUnknownNCT05390073
What this trial is testing

Growth Hormone in EB

Who this might be right for
Epidermolysis Bullosa Dystrophica
Cairo University 50
Testing effectiveness (Phase 2)Study completedNCT05143190
What this trial is testing

Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Phoenix Tissue Repair, Inc. 2
Testing effectiveness (Phase 2)Ended earlyNCT03605069
What this trial is testing

A Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With Confirmed DDEB or RDEB Diagnosis With One or More Pathogenic Mutations in Exon 73 in the COL7A1 Gene

Who this might be right for
Epidermolysis Bullosa Dystrophica, RecessiveEpidermolysis Bullosa Dystrophica, Dominant
Phoenicis Therapeutics 2
Not applicableStudy completedNCT03158662
What this trial is testing

Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Amicus Therapeutics 150
Not applicableStudy completedNCT02670837
What this trial is testing

Study of Cellutome System for Treatment of Individual Lesions in EB Pts

Who this might be right for
Epidermolysis Bullosa
Masonic Cancer Center, University of Minnesota 34
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Large-scale testing (Phase 3)Ended earlyNCT00587223
What this trial is testing

Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)

Who this might be right for
Epidermolysis Bullosa, JunctionalEpidermolysis Bullosa Dystrophica
Organogenesis 1
Testing effectiveness (Phase 2)Looking for participantsNCT06834035
What this trial is testing

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis BullosaEpidermolysis Bullosa AcquisitaDystrophic Epidermolysis Bullosa+1 more
M. Peter Marinkovich 8
Load More Results